1. Home
  2. MIST vs MCHX Comparison

MIST vs MCHX Comparison

Compare MIST & MCHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIST
  • MCHX
  • Stock Information
  • Founded
  • MIST 2003
  • MCHX 2003
  • Country
  • MIST Canada
  • MCHX United States
  • Employees
  • MIST N/A
  • MCHX N/A
  • Industry
  • MIST Biotechnology: Pharmaceutical Preparations
  • MCHX Business Services
  • Sector
  • MIST Health Care
  • MCHX Consumer Discretionary
  • Exchange
  • MIST Nasdaq
  • MCHX Nasdaq
  • Market Cap
  • MIST 81.5M
  • MCHX 79.9M
  • IPO Year
  • MIST N/A
  • MCHX 2004
  • Fundamental
  • Price
  • MIST $1.80
  • MCHX $1.66
  • Analyst Decision
  • MIST Strong Buy
  • MCHX
  • Analyst Count
  • MIST 3
  • MCHX 0
  • Target Price
  • MIST $13.00
  • MCHX N/A
  • AVG Volume (30 Days)
  • MIST 510.8K
  • MCHX 32.5K
  • Earning Date
  • MIST 11-12-2024
  • MCHX 10-31-2024
  • Dividend Yield
  • MIST N/A
  • MCHX N/A
  • EPS Growth
  • MIST N/A
  • MCHX N/A
  • EPS
  • MIST N/A
  • MCHX N/A
  • Revenue
  • MIST N/A
  • MCHX $48,594,000.00
  • Revenue This Year
  • MIST N/A
  • MCHX N/A
  • Revenue Next Year
  • MIST N/A
  • MCHX $4.20
  • P/E Ratio
  • MIST N/A
  • MCHX N/A
  • Revenue Growth
  • MIST N/A
  • MCHX N/A
  • 52 Week Low
  • MIST $1.12
  • MCHX $1.11
  • 52 Week High
  • MIST $3.52
  • MCHX $2.15
  • Technical
  • Relative Strength Index (RSI)
  • MIST 68.42
  • MCHX 50.03
  • Support Level
  • MIST $1.75
  • MCHX $1.73
  • Resistance Level
  • MIST $2.09
  • MCHX $1.90
  • Average True Range (ATR)
  • MIST 0.15
  • MCHX 0.12
  • MACD
  • MIST 0.04
  • MCHX 0.01
  • Stochastic Oscillator
  • MIST 62.86
  • MCHX 63.33

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

About MCHX Marchex Inc. Class B

Marchex Inc is a conversational analytics and solutions company that helps businesses connect, drive, measure, convert callers into customers, and connect the voice of the customer to their business. It delivers data insights and incorporates artificial intelligence (AI)-powered functionality that drives insights and solutions to help companies find, engage, and support their customers across voice and text-based communication channels. The group enables sales and marketing teams to deliver the buying experiences that today's customers expect. The company generates the majority of its revenues from core analytics and solutions services. The company operates in the United States, Canada, and other countries.

Share on Social Networks: